Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
10/2001
10/17/2001EP1144366A2 Use of androgen receptor suppressors
10/17/2001EP1143991A2 Inhibitors of h+k+ -atpase
10/17/2001EP1143965A1 Carbocyclic potassium channel inhibitors
10/17/2001EP1143960A2 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases
10/17/2001EP1143951A2 Antimalarial agents
10/17/2001EP1143933A2 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
10/17/2001EP1143916A2 Topical compositions comprising protected functional thiols
10/17/2001CN1318051A Novel urea derivatives bearing nitrogenous aromatic heterocycles
10/17/2001CN1317966A Utilization of aryl (or heteroaryl) azolylcarbinol derivatives in prepn. of medicament for treating troubles mediated by excess of substance P
10/17/2001CN1073103C Compounds and compsns. for treating diseases associated with tryptase activity
10/16/2001US6303720 Olefin polymerization catalysts containing group 8-10 transition metals, processes employing such catalysts and polymers obtained therefrom
10/16/2001US6303660 Enhanced anti-cancer agent delivery to solid tumors by primer compounds
10/16/2001US6303659 Administering adamantane derivative for therapy of rheumatoid arthritis
10/16/2001US6303640 Administering oxazole or thiazole derivative compound for reducing side effects of diabetic therapy
10/16/2001US6303608 2-{4-[4-(4,5-dichloro-2-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluoropyrimidine, its preparation and its therapeutic use
10/16/2001US6303312 Modifying cell phenotype; medical research and therapy
10/16/2001US6303079 Mixture of quaternized amido imidazoline and quaternized amino imidazole.
10/16/2001CA2137296C Phospholipid derivative and reactive vesicle-forming agent
10/11/2001WO2001074792A2 Process for the preparation of matrix metalloproteinase inhibitors
10/11/2001WO2001074788A1 2-hydroxy-mutilin carbamate derivatives for antibacterial use
10/11/2001WO2001074780A1 Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist
10/11/2001WO2001074757A1 Process for the selective n-formylation of n-hydroxylamines
10/11/2001WO2001074753A1 Synthetic derivatives of lunularic acid, medicaments containing said compounds, method for producing the lunularic acid derivatives and the use thereof
10/11/2001WO2001074743A1 Novel late transition metal catalyst complexes and oligomers therefrom
10/11/2001WO2001074741A2 Catalytic asymmetric desymmetrization of meso compounds
10/11/2001WO2000016763A3 Antimalarial agents
10/11/2001DE10015525A1 Synthetische Derivate von Lunularsäure, Arzneimittel enthaltend diese Verbindung, Verfahren zur Herstellung der Lunularsäurederivate sowie deren Verwendung Synthetic derivatives of Lunularsäure, to medicaments containing this compound, methods of making them and their use of the Lunularsäurederivate
10/11/2001CA2405535A1 Catalytic asymmetric desymmetrization of meso compounds
10/11/2001CA2405132A1 2-hydroxy-mutilin carbamate derivatives for antibacterial use
10/11/2001CA2404017A1 Novel late transition metal catalyst complexes and oligomers therefrom
10/11/2001CA2403885A1 Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist
10/11/2001CA2403529A1 Process for the selective n-formylation of n-hydroxylamines
10/10/2001EP1142909A1 Novel guanosine triphosphate (gtp)-binding protein-coupled receptor protein
10/10/2001EP1142879A1 Imidazole compounds and medicinal use thereof
10/10/2001EP1142868A1 Amide derivatives
10/10/2001EP1140906A1 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
10/10/2001EP1140864A2 Vitronectin receptor antagonist pharmaceuticals
10/10/2001EP1140858A2 Arylpropenylimidazoles as farnesyl-protein transferase inhibitors
10/10/2001EP1140857A1 Synthesis of histamine dihydrochloride
10/10/2001EP1140819A1 Alfa-sulfenimino acid derivatives
10/10/2001EP1140814A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/10/2001EP1140809A1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
10/10/2001EP1140802A1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines
10/10/2001EP1140794A1 Novel method for preparing chiral amino acids
10/10/2001EP1140792A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by vla-4
10/10/2001EP1140783A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp
10/10/2001EP1140181A1 Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia
10/10/2001EP1140066A1 Nitrosated and nitrosylated h2 receptor antagonist compounds, compositions and methods of use
10/10/2001EP0897556B1 Silver-halide recording material with improved storage stability to produce negatives with ultrahard-gradation contrast
10/10/2001EP0770071B1 Sulfonamide derivatives of azolones anti-helicobacter agents
10/10/2001CN1316414A Method for preparing optically active semi-ester
10/10/2001CN1072651C Intermediates for preparation of 2-imidzaoline-5-ones
10/10/2001CN1072647C Novel inhibitors of bone reabsorption and antagonists of vitronectin receptors
10/09/2001US6300503 Hydantoin intermediates for the synthesis of omapatrilat and methods for producing and using the same
10/09/2001US6300501 Histidine-(N-benzyl glycinamide) inhibitors of protein farnesyl transferase
10/09/2001US6300410 Useful in coating, ink and adhesives, paints
10/09/2001CA2202057C 5-lipoxygenase inhibitors
10/04/2001WO2001072728A2 Novel piperazine derivatives
10/04/2001WO2001072716A1 An intermediate and process for its synthesis
10/04/2001WO2001072715A2 N-halamine vinyl compounds and their polymeric biocides
10/04/2001WO2001072703A1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
10/04/2001WO2001072702A2 Amidino compounds useful as nitric oxide synthase inhibitors
10/04/2001WO2001072689A2 Method for separating a basic amino acid from fermentation broth
10/04/2001WO2001072687A1 Diphenyl ether compounds useful in therapy
10/04/2001WO2001072685A2 Polyamine analogues as cytotoxic agents
10/04/2001WO2001021577A3 Melanin concentrating hormone antagonist
10/04/2001WO2000034255A9 Substituted thiazoles for treatment of human diseases involving modulators of p-, l- and e- selectin
10/04/2001WO2000033836A9 5-membered heterocycles for the treatment of human diseases involving modulators of selectins
10/04/2001US20010027203 Chemical complex comprising a pyridine carboxy derivative and an H2 histamine receptor antagonist
10/04/2001US20010027201 Non-systemic control of parasites
10/04/2001US20010027200 PPARgamma modulators
10/04/2001US20010026890 Nonaqueous
10/04/2001EP1137839A2 Method for treating polyolefine- or polyester-based fibers to render them hydrophilic using heterocycles
10/04/2001EP1137647A1 Thiourea inhibitors of herpes viruses
10/04/2001EP1137640A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
10/04/2001EP0973395A4 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them
10/04/2001CA2404626A1 Novel piperazine derivatives
10/04/2001CA2404439A1 Diphenyl ether compounds useful in therapy
10/04/2001CA2404255A1 N-halamine vinyl compounds and their polymeric biocides
10/04/2001CA2403814A1 Polyamine analogues as cytotoxic agents
10/03/2001CN1315321A Process for preparing oxazoline compound
10/03/2001CN1072252C Silicate-, borate-and nitrate-free antifreeze concentrates and coolant compositions comprising them
10/03/2001CN1072223C Halogen pyrimidines, its preparing process and pesticide containing same
10/03/2001CN1072221C 3-halo-3-heteroaryl carboxylic acid derivatives, method of preparing them and intermediates
10/03/2001CN1072210C 1-phenylpyrazole-3-carboxamides acting on neurotensin receptors
10/02/2001US6297374 Nitroimino-nitromethylene—azole or-azine heterocyclic compounds, insecticidal compositions containing them, and insecticidal methods of using them
10/02/2001US6297284 Aza-enediyne, aza-enyne allene, or an aza-diallene cationic compounds that bind to nucleic acids.
10/02/2001US6297239 Inhibitors of prenyl-protein transferase
10/02/2001CA2022628C Coating compositions containing 1,3-dialkylimidazole-2-thione catalysts
09/2001
09/27/2001WO2001070757A2 Thioketals and thioethers for inhibiting the expression of vcam-1
09/27/2001WO2001070720A2 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors
09/27/2001WO2001070703A2 Substituted 1-(4-aminophenyl)imidazoles and their use as anti-inflammatory agents
09/27/2001WO2001070693A2 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors
09/27/2001WO2001070682A2 Carbocyclic side chain containing metalloprotease inhibitors
09/27/2001WO2001070677A1 Sulphonamido-substituted bridged bicycloalkyl derivatives
09/27/2001WO2001070649A1 Method for reducing organic compounds in a microreactor by means of hydrides and/or the derivatives thereof
09/27/2001WO2001070217A1 Dna-cleaving antitumor agents
09/27/2001WO2001060822A8 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
09/27/2001WO2000061541A3 Pharmaceutical compounds
09/27/2001WO2000061537A3 Pharmaceutical compounds
1 ... 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 ... 345